Country Trust Bank’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-85
Closed -$10.9K 567
2025
Q1
$10.9K Hold
85
﹤0.01% 241
2024
Q4
$11.2K Hold
85
﹤0.01% 252
2024
Q3
$12.4K Hold
85
﹤0.01% 245
2024
Q2
$11.7K Buy
85
+50
+143% +$6.67K ﹤0.01% 241
2024
Q1
$4.8K Buy
+35
New +$4.78K ﹤0.01% 263
2022
Q2
Sell
-126
Closed -$16K 389
2022
Q1
$16K Hold
126
﹤0.01% 279
2021
Q4
$19K Sell
126
-196
-61% -$30.3K ﹤0.01% 288
2021
Q3
$52K Sell
322
-50
-13% -$8.41K ﹤0.01% 206
2021
Q2
$61K Hold
372
﹤0.01% 190
2021
Q1
$56K Hold
372
﹤0.01% 195
2020
Q4
$56K Hold
372
﹤0.01% 178
2020
Q3
$50K Buy
+372
New +$50.5K ﹤0.01% 168

Other funds holding IBB

Country Trust Bank's IBB Position: Q2 2025 in Review

Country Trust Bank sold out of iShares Biotechnology ETF (IBB) in Q2 2025, closing a stake of 85 shares — an estimated $10.9K sold.

Country Trust Bank first reported a position in IBB in Q3 2020 and held it in 12 quarters. The position peaked at $61K in Q2 2021. 797 funds tracked by Wall St. Rank hold IBB as of Q2 2025.

  • Country Trust Bank reported no remaining iShares Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
  • Country Trust Bank sold 85 iShares Biotechnology ETF shares in Q2 2025, an estimated $10.9K.
  • Country Trust Bank first reported a position in iShares Biotechnology ETF in Q3 2020 and held it in 12 quarters.
  • Country Trust Bank's iShares Biotechnology ETF position peaked at $61K in Q2 2021.
  • 797 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2025.

Based on Country Trust Bank's 13F filing for Q2 2025, filed 12 Aug 2025.